Rural emergency department best practice for treatment of acute ischemic stroke

Similar documents
GUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE

Acute Stroke Protocols Modified- What s New in 2013

NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS. ACUTE CEREBROVASCULAR ACCIDENT TPA (ACTIVASE /alteplase) FOR THROMBOLYSIS

Primary Stroke Center Acute Stroke Transfer Guidelines When to Consider a Transfer:

Protocol for IV rtpa Treatment of Acute Ischemic Stroke

ENCHANTED Era: Is it time to rethink treatment of acute ischemic stroke? Kristin J. Scherber, PharmD, BCPS Emergency Medicine Clinical Pharmacist

Emergency Department Management of Acute Ischemic Stroke

KPNC Stroke EXPRESS EXpediting the PRocess of Evaluating & Stopping Stroke

ACCESS CENTER:

ACUTE ISCHEMIC STROKE. Current Treatment Approaches for Acute Ischemic Stroke

Disclosures. Outline. Updated Recommendations for Using Alteplase (TPA) in Acute Ischemic Stroke

Journal Club. 1. Develop a PICO (Population, Intervention, Comparison, Outcome) question for this study

Unclogging The Pipes. Zahraa Rabeeah MD Chief Resident February 9,2018

BY: Ramon Medina EMT-LP/RN

Acute Stroke Care: the Nuts and Bolts of it. ECASS I and II ATLANTIS. Chris V. Fanale, MD Colorado Neurological Institute Swedish Medical Center

o Unenhanced Head CT

Interventions to Improve Acute Ischemic Stroke Treatment Times

2018 Early Management of Acute Ischemic Stroke Guidelines Update

Stroke Update. Lacunar 19% Thromboembolic 6% SAH 13% ICH 13% Unknown 32% Hemorrhagic 26% Ischemic 71% Other 3% Cardioembolic 14%

Updated Ischemic Stroke Guidelines นพ.ส ชาต หาญไชยพ บ ลย ก ล นายแพทย ทรงค ณว ฒ สาขาประสาทว ทยา สถาบ นประสาทว ทยา กรมการแพทย กระทรวงสาธารณส ข

Stroke Update Elaine J. Skalabrin MD Medical Director and Neurohospitalist Sacred Heart Medical Center Stroke Center

Endovascular Treatment Updates in Stroke Care

Emergency Treatment of Ischemic Stroke

Jointly provided by Potomac Center for Medical Education and Rockpointe Supported by an educational grant from Genentech, A Member of the Roche Group

Stroke: The First Critical Hour. Alina Candal, RN, PCC, MICN Kevin Andruss, MD, FACEP

ENDOVASCULAR THERAPIES FOR ACUTE STROKE

Updated tpa Guidelines: Expanding the opportunity for good outcomes. Benjamin Morrow, MSN RN UPMC Stroke Institute

The Multi arm Optimization of Stroke Thrombolysis (MOST) Trial

Door to Needle Time: Gold Standard of Stroke Treatment Fatima Milfred, MD. Virginia Mason Medical Center March 16, 2018

Stroke Systems of Care Claire Corbett, MMS, NRP Manager of Neurodiagnostics and Stroke Center New Hanover Regional Medical Center. What do we know?

How to Interpret CT/CTA for Acute Stroke in the Age of Endovascular Clot Retrieval

Acute Stroke Rescue and Recovery

Acute Stroke Treatment: Current Trends 2010

The Importance of Stroke Programs in an Acute Care Setting by Debbie Estes, RN, BSN Stroke Program Coordinator, Medical City of Dallas

Shawke A. Soueidan, MD. Riverside Neurology & Sleep Specialists

Practical Considerations in the Early Treatment of Acute Stroke

Mechanical thrombectomy in Plymouth. Will Adams. Will Adams

Stroke in the Rural Setting: How You Can Make A Difference. Susie Fisher, RN, BSN Program Manager Providence Stroke Center Portland, OR

ND STROKE Coordinators Case Studies. STEMI and Stroke Conference, Fargo, ND, August 5, 2014

Dawn Matherne Meyer PhD,RN,FNP-C. Assistant Professor University of California San Diego

Advancing Stroke Systems of Care to Improve Outcomes Update on Target: Stroke Phase II

Endovascular Treatment for Acute Ischemic Stroke

Emergency Room Procedure The first few hours in hospital...

Stroke Transfer Checklist

Managing the Measures: A Serious Look at Key Abstraction Concepts for the Comprehensive Stroke (CSTK) Measure Set Session 2

Acute ischemic stroke is a major cause of morbidity

Table 1. Specific changes to the FDA labeling for recombinant tissue plasminogen activator (Alteplase, Activase, Genentech, inc).

Management of Acute Ischemic Stroke. Learning Objec=ves. What is a Stroke? Jen Simpson Neurohospitalist

Comparison of Five Major Recent Endovascular Treatment Trials

9/24/2013. Thrombolytics in 2013: Never Say Never. September 19 th, 2013 Scott M Lilly, MD PhD. Clinical Case

Interventional Stroke Treatment

WV Appalachian Stroke Network 2016 State Stroke Conference The Big Decision Packaging the Patient for Transfer

Neuro-vascular Intervention in Stroke. Will Adams Consultant Neuroradiologist Plymouth Hospitals NHS Trust

Disclosure. Advances in Interventional Neurology. Disclosure. Natural History of Disease 3/15/2018. Vishal B. Jani MD

COMPREHENSIVE SUMMARY OF INSTOR REPORTS

11/1/2018. Disclosure. Imaging in Acute Ischemic Stroke 2018 Neuro Symposium. Is NCCT good enough? Keystone Heart Consultant, Stock Options

CVA Updates Karen Greenberg, DO, FACOEP. Director Neurologic Emergency Department Crozer Chester Medical Center

Case 1 5/26/2017 ENDOVASCULAR MECHANICAL THROMBECTOMY IN PATIENTS WITH ACUTE ISCHEMIC STROKE

Disclosures. Anesthesia for Endovascular Treatment of Acute Ischemic Stroke. Acute Ischemic Stroke. Acute Stroke = Medical Emergency!

Thrombolysis administration

Drano vs. MR CLEAN Review of New Endovascular Therapy for Acute Ischemic Stroke Patients

Acute Stroke Identification and Treatment

Stroke Belt Consortium

ST Elevated Myocardial Infarction- Latest AHA recommendations

Primary Stroke Center Quality & Performance Measures

Get With the Guidelines Stroke PMT. Quality Measure Descriptions

Stroke Guidelines. November 19, 2011

Pathophysiology of stroke

Stroke Systems of Care

UPDATES IN INTRACRANIAL INTERVENTION Jordan Taylor DO Metro Health Neurology 2015

Mercy University Hospital Stroke Service. Protocol for IV Thrombolysis for cerebral infarction

Antithrombotics: Percent of patients with an ischemic stroke or TIA prescribed antithrombotic therapy at discharge. Corresponding

Stroke Thrombolysis. Dr Peter Anderton (Stroke Consultant DBTH)

ACUTE ISCHEMIC STROKE

The DAWN of a New Era for Wake-up Stroke

Stroke Clinical Trials Update Transitioning to an Anatomic Diagnosis in Ischemic Stroke

Stroke 101. Maine Cardiovascular Health Summit. Eileen Hawkins, RN, MSN, CNRN Pen Bay Stroke Program Coordinator November 7, 2013

Mechanical thrombectomy beyond the 6 hours. Mahmoud Rayes, MD Medical Director, Stroke program Greenville Memorial Hospital

Role of recombinant tissue plasminogen activator in the updated stroke approach

Mechanical Thrombectomy: Where Are We Now? T. Adam Oliver, MD Tallahassee Neurological Clinic Tallahassee, Florida TMH Neurosymposium June 11, 2016

5/31/2018. Interventional Therapies that Expand Time Windows for Acute Ischemic Stroke Treatment. Disclosures. Impact of clot burden

Disclosure. + Outline. What is a stroke? Role of imaging in stroke Ischemic stroke Venous infarct Current topics

OHSU HEALTH CARE SYSTEM PRACTICE GUIDELINES

Acute Stroke Management 2009

Acute Stroke Management Conference 2019: Stroke Clinical Vignettes

Code Stroke for Hospital Medicine: Clinical Challenges in Inpatient Care

Advanced Stroke Care in the context of the Cardiovascular Patient

Canadian Best Practice Recommendations for Stroke Care. (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management

Broadening the Stroke Window in Light of the DAWN Trial

Recent Changes in IV TPA Recommendations. Ashish Masih, M.D Vascular Neurology

Stroke, Stroke, Stroke Where Do We Stop on the River? Comprehensive vs. Primary Stroke Centers

Identifying Key Players for Early Stroke Management

Code Stroke in real life. Disclosures. Parkland Memorial Hospital. I have no disclosures. Has 1 million patient visits annually. Level 1 Trauma Center

Endovascular Stroke Therapy

Thrombolytic therapy should be the first line treatment in acute ishchemic stroke. We are against it!!

Updates in Stroke Management. Jessica A Starr, PharmD, FCCP, BCPS Associate Clinical Professor Auburn University Harrison School of Pharmacy

Endovascular Neurointervention in Cerebral Ischemia

ACUTE STROKE TREATMENT IN LARGE NIHSS PATIENTS. Justin Nolte, MD Assistant Profession Marshall University School of Medicine

Shands at the University of Florida Stroke Program

AGWS Stroke Thrombolysis Clinical Profoma

Transcription:

Rural emergency department best practice for treatment of acute ischemic stroke Aubrey J. Hoye, DO Ministry Howard Young Medical Center, Woodruff, WI Ministry Eagle River Memorial Hospital, Eagle River, WI OSF St. Francis Medical Center, Peoria, IL

DISCLOSURES NONE Mention of off label use of tpa in pediatric population

problem Many patients with ischemic stroke are not treated with tpa: Late presentation to the ED Delays in assessment/administration of IV tpa Lack of urgency in stroke treatment is poorly appreciated Earlier administration of IV tpa after the onset of stroke symptoms is directly associated with greater functional recovery For every 1 minute of ischemic stroke, 1.9 million neurons die One of the potential approaches to increase treatment opportunities and improve stroke outcomes is to provide this treatment in a more timely fashion Reduce door to needle time for administration of tpa

Ischemic penumbra Severity of ischemic stroke depends on: degree of impairment of cerebral blood flow and the time to reperfusion. Between the ischemic core and normally perfused brain is the penumbra zone of moderately reduced cerebral blood flow, dependent on the proximal arterial occlusion and collateral supply Hypoxic neurons, inactive STILL VIABLE Target of stroke treatment

AHA Guidelines IV tpa is recommended for selected patients who may be treated within 3 hours of onset of ischemic stroke (Class I Recommendation, Level of Evidence A). tpa should be administered to eligible patients who can be treated in the time period of 3 to 4.5 hours after stroke (Class I Recommendation, Level of Evidence B). Despite this additional treatment window, opportunity for improvement is greatest with early treatment Remember, 1.9 million neurons die per minute they are hypoxic TIME IS BRAIN.

NUMBER OF PATIENTS WHO BENEFIT AND ARE HARMED PER 100 PATIENTS TREATED WITH TPA IN EACH TIME WINDOW 30.0 27.0 25.0 22.2 20.0 15.9 Benefit 15.0 10.0 7.1 5.0 5.0 1.3 5.0 2.4 0.0 0-90 Lansberg et al, Stroke 2009 91-180 181-270 271-360 Harm

Number needed to treat Number of patients that you need to treat with IV tpa for near normal or normal recovery from ischemic CVA is 8.3 That means, for every 100 patients treated, 32 patients benefit. 3 are harmed What does this compare to? NNT for aspirin in STEMI is 42 for one patient to survive because they received ASA. (Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet, 1998 Aug 13;2(8607):349-60 PMID: 2899772.) So when we give aspirin so freely, because it s a core measure, why are we not having the same attitude with tpa in tx of CVA?

Again, time is brain Hacke, W., G. Donnan, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-pa stroke trials. Lancet 2004;363:768-74. This article was data from 6 randomized placebocontrolled trials of tpa. Treatment was started within 6 hours of onset of stroke in 2775 patients they received either tpa or placebo Favorable outcome (at 3 mo) increased as time to tpa tx decreased so the sooner it was given, the better And the best outcomes were seen in the group of patients who received tpa within 90 mins of symptom onset Confidence intervals fell below 1 in the 4.5-6 hr group

So how does this translate to your ed?

Ed goals for management of stroke Identify signs/symptoms of possible stroke If prehospital (EMS), establish time of onset Alert the ED that you have a stroke patient Check glucose General Assessment/Stabilization: 0-10 mins ABCs, O2, IV, accucheck, neuro assessment, order emergent CT, EKG, activate a stroke team (who has one?) Door to CT an option if stroke called prehospital Does your CT scanner need time to warm up? ED Physician: 10-25 mins (can be simultaneous) Focused history and physical exam, laboratories, call for consult (neuro/telestroke, etc) Who has neuro consult available? Who has telestroke? NIHSS, time of onset

ED GOALS FOR MANAGEMENT OF STROKE CT Scan and Stroke Neurology Consult: 25-45 mins Interpret CT Scan Where are you radiologists? In house, at a related center, in Hawaii, or do you have Nighthawk? How many of you get a result back in 0-45 mins from the patient arrival? No hemorrhage? Decide on treatment and initiate tpa infusion: 45-60 mins Where is your tpa? Pyxis or in pharmacy? Do you know dosing? Pt weight? Bolus dose, followed by drip over one hour? Be sure to flush tubing.

BEST Practice Door to CT: 25 mins CT results back to you: 45 mins tpa given: within 60 mins

Inclusion criteria Diagnosis of ischemic stroke Onset of symptoms <3 hours before treatment OR 34.5 hours before treatment Age >18 years Would you ever tpa someone younger than this? It is currently off label use.

3 HOUR EXCLUSION CRITERIA Head trauma/prior CVA in last 3 months Active internal bleeding or acute trauma Symptoms suggestive of SAH Recent intracranial or intraspinal surgery Arterial puncture at NONCOMPRESSIBLE site in previous 7 days Taking an oral anticoagulant, OR if on one, INR <1.7 or PT <15 Hx of prior ICH Intracranial neoplasm/aneurysm/avm Taking a direct thrombin inhibitor or factor Xa inhibitor within 48 hours OR with elevated PTT, INR, TT, or factor Xa assay Systolic BP >185 or Diastolic BP >110 mg at time of treatment (may give labetalol, nicardipine, hydralazine prior to treatment to get BP in goal range) Platelets <100,000 Blood glucose <50 CT shoes multilobular infarction

3 hour relative contraindications GI or GU hemorrhage (not menstruation) in previous 21 days Major surgery/trauma in last 14 days MI in last 3 months Seizure at onset with residual postictal state Pregnancy Minor or rapidly improving neurologic symptoms

3 to 4.5 hour window Eligibility is the same for those who are candidates for 3 hour window, with the following exclusions: Patients older than 80 NIHSS >25 Those taking an oral anticoagulant REGARDLESS of INR Hx of both CVA and DM

NIHSS http://nihssenglish.trainingcampus.net/uas/modules/trees/windex.aspx Take on online course to better understand the scoring Found in the tpa booklet Also, a nice app for smartphone users is Neuro Toolkit Includes the pictures for aphasia Link to pdf: http://www.ninds.nih.gov/doctors/nih_stroke_scale.pdf Score should not be an indicator of whether or not patient receives tpa (unless >25 in 3-4.5 hr window) An educated discussion should be made with patient and family regarding their wishes to receive treatment; a score of 4 may be devastating for the patient

Consent to Administer Alteplase (tpa) Physician Name: ha s informed me of the risks and benefits for utilizing Alteplase, a tissue plasminogen activator (tpa) to treat the acute ischemic strok I am now experiencing. consent I understand that the Potential Benefits of Alteplase include the following: Likelihood of improvement of stroke symptoms such as, extremity weakness, impaired spee and/or visual problems up to three months after onset of symptoms. I understand that the Potential Major Risks of Alteplase include the following: Likelihood of significant bleeding in the brain within 36 hours of treatment A list of contraindications has been reviewed with me. I understand and agree that I have no contraindications. I understand that I will be transferred to the critical care area after receiving the treatment and will remain there for a minimum of 24 hours. http://www.strokecarenow.com/pdfs/ tpa%20consent.pdf I CONSENT to the administration of Alteplase for my symptoms. I REFUSE the administration of Alteplase for my symptoms. By signing this form, I am indicating I understand the contents of this document, agree to its provisions and consent or refuse as noted above to the administration of Alteplase. I know if I have concerns or would like more detailed information, I can ask more questions and get more information from my attending physician. I am also acknowledging I know that the administration of Alteplase is not an exact science and that no guarantees about the outcome of this treatment have been made. Printed Name of Patient Signature of Patient or Person Authorized to Consent for Patient / / at : am Date Time Printed Name of Person Authorized to Consent for Patient Relationship Witness Signature / / at : am Date Time Printed Name of Witness I certify that I have discussed the benefits, risks, and alternatives with this patient. Signature of Physician Printed Name of Physician / / at : am Date Time

fact sheet to facilitate decision» Get With the Guidelines» tpa consent tpa Fact Sheet» tpa dosing chart» NIH Stroke Scale Helps with informed consent Have printed this and given to patients and their families to help with decision making on if they are agreeable to treatment http://www.strokecarenow.com/for_h ealthcare_providers/tpa_fact_sheet.ht ml IV tpa vs. no treatment» IV tpa Inclusion/Exclusion Criteria Onset to treatment within 3 hours» tpa Fact Sheet Good outcome with no or minimal deficit 3 months after stroke: 39% vs. 26% Risk of brain bleeding with worsening neurological status 6.4 % vs. 0.6%» Order Sets» Post-tPA Vital Sign/Neurocheck Form Risk of Death: 17% vs. 21% Overall, for every 100 patients treated within the first 3 hours, 32 had a better outcome as a result and 3 a worse outcome. Brain hemorrhages related to tpa caused severe worsened final outcome in only 1% of patients. Patients who are treated with IV tpa are discharged home earlier, are more often discharged home versus to a nursing home and report a better quality of life. For every 8 patients treated, 1 has a near normal outcome. For every third patient treated, one has an improved outcome. Patient with a Stroke that... Had IV tpa treatment No treatment Good outcome with no or minimal deficit 3 months after stroke 39% Risk of brain bleeding with worsening neurological status 6.4% 0.6% Risk of Death 17% 21% 2009 StrokeCareNow 26%

Best Practice EMS Activation/Notification Have EMS trained in identification of acute CVA Early notification can reduce time to CT Activate your Stroke Team Don t have one? Make one include lab, CT technicians, radiologist reading the CT, pharmacy, neurology (if you have them), etc. One call either as a page or central operator Stroke Toolkit Have standardized order sets/protocols, NIHSS available, hospital specific algorithms or other tools readily available tpa consent form, contraindication checklists

BEST PRACTICE Imaging in 25 mins from arrival, report back in 45 mins Get your radiology team on board one call to all Rapid laboratory results Should be drawn in first 10 mins of arrival. If lab comes to your ED to draw, they need to be part of one call to all Need to have platelets and coags back w/in 45 mins from arrival If this is not feasible, consider investing in point of care testing

Best practice Mix tpa ahead of time Get it out when your patient is going to the scanner Go to the scanner and discuss contraindications w/pt, as well as risks/benefits, etc. This way, you can treat at the earliest possible time from onset Discuss this financially with your institution (mixing before deciding to give) you may be able to be reimbursed by vendor for not using it TIME IS BRAIN.

WHAT IF TIME OF ONSET IS >4.5 HRS OR UNKNOWN If your acute CVA patient is not a candidate for IV tpa therapy, there are other options, and this warrants transfer to an institution with neurology/ir capability for endovascular treatment options Even if your patient qualifies, approx. 20% of pts with large vessel occlusions reperfuse may still require endovascular intervention PROACT trial intra-arterial thrombolysis beneficial up to 6 hours s/p onset MERCI, Multi-MERCI and Penumbra trials mechanical thrombectomy has been successful 8 hours after onset

VIDEO Door to Needle Goals

IN closing Get everyone to work as a team EMS, RNs, registration, radiology (techs and physicians), laboratory, pharmacy If your ED physician is in another room, kindly interrupt that potentially nonemergent visit Make one call to all Code stroke whatever you want to call it Find a way to follow your progress (director of quality) Where are your barriers? Are you meeting your goals sometimes vs. not at other times? Don t be afraid to give tpa You give lytics a lot more often for STEMI It is the only FDA approved treatment for stroke Praise your team for a job well done if and when you meet a door to needle time of < 60 minutes Save brains!